Skip to main navigation Skip to search Skip to main content

A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24

  • Ellen L. Goode
  • , Georgia Chenevix-Trench
  • , Honglin Song
  • , Susan J. Ramus
  • , Maria Notaridou
  • , Kate Lawrenson
  • , Martin Widschwendter
  • , Robert A. Vierkant
  • , Melissa C. Larson
  • , Susanne K. Kjaer
  • , Michael J. Birrer
  • , Andrew Berchuck
  • , Joellen Schildkraut
  • , Ian Tomlinson
  • , Lambertus A. Kiemeney
  • , Linda S. Cook
  • , Jacek Gronwald
  • , Montserrat Garcia-Closas
  • , Martin E. Gore
  • , Ian Campbell
  • Alice S. Whittemore, Rebecca Sutphen, Catherine Phelan, Hoda Anton-Culver, Celeste Leigh Pearce, Diether Lambrechts, Mary Anne Rossing, Jenny Chang-Claude, Kirsten B. Moysich, Marc T. Goodman, Thilo Dörk, Heli Nevanlinna, Roberta B. Ness, Thorunn Rafnar, Claus Hogdall, Estrid Hogdall, Brooke L. Fridley, Julie M. Cunningham, Weiva Sieh, Valerie McGuire, Andrew K. Godwin, Daniel W. Cramer, Dena Hernandez, Douglas Levine, Karen Lu, Edwin S. Iversen, Rachel T. Palmieri, Richard Houlston, Anne M. Van Altena, Katja K.H. Aben, Leon F.A.G. Massuger, Angela Brooks-Wilson, Linda E. Kelemen, Nhu D. Le, Anna Jakubowska, Jan Lubinski, Krzysztof Medrek, Anne Stafford, Douglas F. Easton, Jonathan Tyrer, Kelly L. Bolton, Patricia Harrington, Diana Eccles, Ann Chen, Ashley N. Molina, Barbara N. Davila, Hector Arango, Ya Yu Tsai, Zhihua Chen, Harvey A. Risch, John McLaughlin, Steven A. Narod, Argyrios Ziogas, Wendy Brewster, Aleksandra Gentry-Maharaj, Usha Menon, Anna H. Wu, Daniel O. Stram, Malcolm C. Pike, Jonathan Beesley, Penelope M. Webb, Xiaoqing Chen, Arif B. Ekici, Falk C. Thiel, Matthias W. Beckmann, Hannah Yang, Nicolas Wentzensen, Jolanta Lissowska, Peter A. Fasching, Evelyn Despierre, Frederic Amant, Ignace Vergote, Jennifer Doherty, Rebecca Hein, Shan Wang-Gohrke, Galina Lurie, Michael E. Carney, Pamela J. Thompson, Ingo Runnebaum, Peter Hillemanns, Matthias Dürst, Natalia Antonenkova, Natalia Bogdanova, Arto Leminen, Ralf Butzow, Tuomas Heikkinen, Kari Stefansson, Patrick Sulem, Sören Besenbacher, Thomas A. Sellers, Simon A. Gayther, Paul D.P. Pharoah
  • Mayo Clinic Rochester, MN
  • Post Office Royal Brisbane Hospital
  • University of Cambridge
  • University College London
  • University of Copenhagen
  • Danish Cancer Society
  • Massachusetts General Hospital
  • Duke University
  • Queen Mary University of London
  • Radboud University Nijmegen
  • University of New Mexico
  • Alberta Health Services
  • Pomeranian Medical University in Szczecin
  • National Institutes of Health
  • Royal Marsden NHS Foundation Trust
  • Peter Maccallum Cancer Centre
  • University of Melbourne
  • Stanford University
  • University of South Florida
  • Moffitt Cancer Center
  • University of California at Irvine
  • University of Southern California
  • Flanders Institute for Biotechnology
  • Fred Hutchinson Cancer Research Center
  • German Cancer Research Center
  • University of Hawai'i at Mānoa
  • Hannover Medical School
  • Helsinki University Hospital
  • University of Texas Health Science Center at Houston
  • deCODE genetics
  • Fox Chase Cancer Center
  • Brigham and Women’s Hospital
  • Memorial Sloan-Kettering Cancer Center
  • University of Texas MD Anderson Cancer Center
  • University of North Carolina at Chapel Hill
  • The Institute of Cancer Research
  • Netherlands Association of Comprehensive Cancer Centres
  • Provincial Health Services Authority
  • Simon Fraser University
  • University of Southampton
  • Yale University
  • Cancer Care Ontario
  • West Coast Gynecologic Oncology
  • University of Toronto
  • Friedrich-Alexander University Erlangen-Nürnberg
  • Maria Sklodowska-Curie Institute of Oncology
  • University of California at Los Angeles
  • KU Leuven
  • Ulm University
  • Friedrich Schiller University Jena
  • Byelorussian Institute for Oncology and Medical Radiology Aleksandrov N.N.

Research output: Contribution to journalArticlepeer-review

313 Scopus citations

Abstract

Ovarian cancer accounts for more deaths than all other gynecological cancers combined. To identify common low-penetrance ovarian cancer susceptibility genes, we conducted a genome-wide association study of 507,094 SNPs in 1,768 individuals with ovarian cancer (cases) and 2,354 controls, with follow up of 21,955 SNPs in 4,162 cases and 4,810 controls, leading to the identification of a confirmed susceptibility locus at 9p22 (in BNC2). Here, we report on nine additional candidate loci (defined as having P 10 -4) identified after stratifying cases by histology, which we genotyped in an additional 4,353 cases and 6,021 controls. We confirmed two new susceptibility loci with P -5 × 10 -8 (8q24, P = 8.0 × 10 -15 and 2q31, P = 3.8 × 10 -14) and identified two additional loci that approached genome-wide significance (3q25, P = 7.1 × 10 -8 and 17q21, P = 1.4 × 10 -7). The associations of these loci with serous ovarian cancer were generally stronger than with other cancer subtypes. Analysis of HOXD1, MYC, TIPARP and SKAP1 at these loci and of BNC2 at 9p22 supports a functional role for these genes in ovarian cancer development.

Original languageEnglish
Pages (from-to)874-879
Number of pages6
JournalNature Genetics
Volume42
Issue number10
DOIs
StatePublished - Oct 2010

Fingerprint

Dive into the research topics of 'A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24'. Together they form a unique fingerprint.

Cite this